The Global Ureteral Stents Market size is expected to reach $883.2 million by 2030, rising at a market growth of 6.5% CAGR during the forecast period. In the year 2022, the market attained a volume of 11,924.9 thousand units experiencing a growth of 6.2% (2019-2022).
Silicone stents are known for their biocompatibility, flexibility, and durability within the body. Their ability to minimize irritation and inflammation in the urinary tract can contribute to increased demand, especially in cases where long-term stenting is necessary. Consequently, the Silicone stents segment would acquire nearly 40% of the total Polymer Stent market share by 2030. Ongoing improvements in silicone stent design, including modifications to reduce migration, enhance drainage, and minimize tissue trauma, drive demand as these devices become more effective and reliable. Some of the factors impacting the market are rising incidences of urological disorders, shift towards minimally invasive procedures in urology and side effects and discomfort associated with the stents.
Kidney stones are a common urological condition, and their incidence has risen globally. Factors such as dietary habits, dehydration, and genetics contribute to the formation of kidney stones. These stents are frequently utilized in managing kidney stones, facilitating the passage of stone fragments, and alleviating symptoms. The incidence of urological tumors, such as bladder or renal cancers, has been on the rise. These stents may be used as part of the treatment strategy for managing obstructions caused by tumors or for post-surgical support. These factors will pose lucrative growth prospects for the market. Additionally, minimally invasive procedures, including the placement of these stents, generally result in quicker recovery times for patients. Compared to traditional open surgeries, which may involve larger incisions and longer recovery periods, minimally invasive techniques are associated with reduced trauma to tissues, allowing patients to recover more swiftly. Smaller incisions and reduced tissue trauma result in a lower level of discomfort for patients undergoing procedures such as ureteral stent placement. These aspects will help in the expansion of the market.
However, the stents can cause an increased sensation of urgency, prompting patients to feel the need to urinate more frequently. This can be bothersome and affect daily activities, potentially leading to disruptions in normal routines. In addition, hematuria, or blood in the urine, is a common side effect of these stents. This can occur due to the stent's irritation of the urinary tract tissues. While it is often not a cause for major concern, it can be alarming for patients and may lead to anxiety. These factors are expected to hamper the growth of the market.
Moreover, one of the significant impacts of the pandemic has been the postponement of elective and non-urgent medical procedures to prioritize resources for COVID-19 patients. Ureteral stent placements, which may be considered elective in certain cases, faced delays as hospitals and healthcare facilities redirected their focus toward managing the pandemic. Additionally, the global supply chain disruptions caused by the pandemic affected the availability of medical devices, including these stents. Manufacturers faced challenges related to production, distribution, and the sourcing of raw materials, which impacted the supply and demand dynamics of the market. Therefore, the COVID-19 pandemic adversely affected the market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Silicone stents are known for their biocompatibility, flexibility, and durability within the body. Their ability to minimize irritation and inflammation in the urinary tract can contribute to increased demand, especially in cases where long-term stenting is necessary. Consequently, the Silicone stents segment would acquire nearly 40% of the total Polymer Stent market share by 2030. Ongoing improvements in silicone stent design, including modifications to reduce migration, enhance drainage, and minimize tissue trauma, drive demand as these devices become more effective and reliable. Some of the factors impacting the market are rising incidences of urological disorders, shift towards minimally invasive procedures in urology and side effects and discomfort associated with the stents.
Kidney stones are a common urological condition, and their incidence has risen globally. Factors such as dietary habits, dehydration, and genetics contribute to the formation of kidney stones. These stents are frequently utilized in managing kidney stones, facilitating the passage of stone fragments, and alleviating symptoms. The incidence of urological tumors, such as bladder or renal cancers, has been on the rise. These stents may be used as part of the treatment strategy for managing obstructions caused by tumors or for post-surgical support. These factors will pose lucrative growth prospects for the market. Additionally, minimally invasive procedures, including the placement of these stents, generally result in quicker recovery times for patients. Compared to traditional open surgeries, which may involve larger incisions and longer recovery periods, minimally invasive techniques are associated with reduced trauma to tissues, allowing patients to recover more swiftly. Smaller incisions and reduced tissue trauma result in a lower level of discomfort for patients undergoing procedures such as ureteral stent placement. These aspects will help in the expansion of the market.
However, the stents can cause an increased sensation of urgency, prompting patients to feel the need to urinate more frequently. This can be bothersome and affect daily activities, potentially leading to disruptions in normal routines. In addition, hematuria, or blood in the urine, is a common side effect of these stents. This can occur due to the stent's irritation of the urinary tract tissues. While it is often not a cause for major concern, it can be alarming for patients and may lead to anxiety. These factors are expected to hamper the growth of the market.
Moreover, one of the significant impacts of the pandemic has been the postponement of elective and non-urgent medical procedures to prioritize resources for COVID-19 patients. Ureteral stent placements, which may be considered elective in certain cases, faced delays as hospitals and healthcare facilities redirected their focus toward managing the pandemic. Additionally, the global supply chain disruptions caused by the pandemic affected the availability of medical devices, including these stents. Manufacturers faced challenges related to production, distribution, and the sourcing of raw materials, which impacted the supply and demand dynamics of the market. Therefore, the COVID-19 pandemic adversely affected the market.
End User Outlook
Based on end user, the market is divided into hospitals and ambulatory surgical centers (ASCS) & clinics. In 2022, the ambulatory surgical centers (ASCS) & clinics segment witnessed a substantial revenue share in the market. ASCs and clinics are well-suited for performing minimally invasive procedures, such as placing stents. ASCs and clinics often provide cost-effective alternatives for surgical and medical procedures compared to traditional hospital settings. The lower overhead costs of these facilities contribute to a more affordable healthcare option for patients, payers, and providers. Thus, these factors will pose lucrative growth prospects for the segment.Material Outlook
Based on material, the market is segmented into metallic stents and polymer stents. In 2022, the polymer stents segment garnered a significant revenue share in the market. Polymer stents are designed to be biocompatible, meaning they are well-tolerated by the body's tissues. This characteristic reduces the risk of tissue irritation, inflammation, and adverse reactions compared to stents made from materials that may be less compatible with the biological environment. Owing to these benefits, the segment will grow rapidly in the coming years.Product Outlook
On the basis of product, the market is divided into double pigtail stent, open/closed pigtail stent, and multiloop stents. In 2022, the open/closed pigtail stent segment witnessed a substantial revenue share in the market. These are specific designs of these stents characterized by a coiled or pigtail structure at one or both ends. The design helps anchor the stent within the urinary tract and prevent migration. The choice between open and closed pigtail stents may depend on factors such as the nature of the urological condition, the patient's anatomy, and the surgeon's preference. The effectiveness of these stents in managing specific cases could influence their adoption. Therefore, these aspects will help in the expansion of the segment.Application Outlook
On the basis of application, the market is divided into kidney transplantation, kidney stones, tumors, urinary incontinence, and others. The kidney transplantation segment held a significant revenue share in the market in 2022. These stents play a crucial role in supporting the postoperative period and ensuring the success of the transplantation. After kidney transplantation, the donor kidney's ureter needs to be connected to the recipient's bladder. The stents are often placed during this surgical procedure to facilitate healing and to ensure proper alignment of the ureter with the bladder. These aspects will boost the demand in the segment.Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America has a relatively high incidence of kidney stones and related urological issues, contributing to the demand for these stents. Continuous advancements in medical technology and the development of innovative stents contribute to market growth. North America, with its strong focus on healthcare research and development, often sees the introduction of new and advanced medical devices, including these stents. Therefore, these aspects will pose lucrative growth prospects for the North America segment.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)- Hospitals
- Ambulatory Surgical Centers (ASCS) & Clinics
- Metallic Stents
- Polymer Stents
- Silicone Ureteral Stents
- Hybrid Ureteral Stents
- Polyurethane Stents
- Double Pigtail Stent
- Open/Closed Pigtail Stent
- Multiloop Stents
- Kidney Stones
- Kidney Transplantation
- Urinary Incontinence
- Tumors
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- B.Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. Global Ureteral Stents Market by End User
Chapter 5. Global Ureteral Stents Market by Material
Chapter 6. Global Ureteral Stents Market by Product
Chapter 7. Global Ureteral Stents Market by Application
Chapter 8. Global Ureteral Stents Market by Region
Chapter 9. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Methodology
LOADING...
